[go: up one dir, main page]

UY25113A1 - Composiciones parenterales de alatrofloxacino - Google Patents

Composiciones parenterales de alatrofloxacino

Info

Publication number
UY25113A1
UY25113A1 UY25113A UY25113A UY25113A1 UY 25113 A1 UY25113 A1 UY 25113A1 UY 25113 A UY25113 A UY 25113A UY 25113 A UY25113 A UY 25113A UY 25113 A1 UY25113 A1 UY 25113A1
Authority
UY
Uruguay
Prior art keywords
parenteral compositions
alatrofloxacino
alatrofloxacin mesylate
alatrofloxacin
mesylate
Prior art date
Application number
UY25113A
Other languages
English (en)
Spanish (es)
Inventor
Robert Mark Guinn
John Francis Lambert
Subramanian Sam Guhan
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY25113A1 publication Critical patent/UY25113A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
UY25113A 1997-08-01 1998-07-28 Composiciones parenterales de alatrofloxacino UY25113A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
UY25113A1 true UY25113A1 (es) 2000-12-29

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25113A UY25113A1 (es) 1997-08-01 1998-07-28 Composiciones parenterales de alatrofloxacino

Country Status (40)

Country Link
US (1) US6194429B1 (sh)
EP (1) EP1000086B1 (sh)
JP (1) JP3463928B2 (sh)
KR (1) KR20010022495A (sh)
CN (1) CN1265671A (sh)
AP (1) AP1031A (sh)
AR (1) AR015417A1 (sh)
AT (1) ATE259827T1 (sh)
AU (1) AU734863B2 (sh)
BG (1) BG104105A (sh)
BR (1) BR9811580A (sh)
CA (1) CA2296466C (sh)
CO (1) CO4970688A1 (sh)
DE (1) DE69821767T2 (sh)
DK (1) DK1000086T3 (sh)
DZ (1) DZ2576A1 (sh)
EA (1) EA002120B1 (sh)
ES (1) ES2214716T3 (sh)
GT (1) GT199800112A (sh)
HN (1) HN1998000106A (sh)
HR (1) HRP980417B1 (sh)
HU (1) HUP0004793A3 (sh)
ID (1) ID24374A (sh)
IL (1) IL134156A0 (sh)
IS (1) IS5339A (sh)
MA (1) MA24626A1 (sh)
NO (1) NO20000485L (sh)
NZ (1) NZ502249A (sh)
OA (1) OA11281A (sh)
PA (1) PA8456701A1 (sh)
PE (1) PE103799A1 (sh)
PL (1) PL338477A1 (sh)
PT (1) PT1000086E (sh)
SK (1) SK1012000A3 (sh)
TN (1) TNSN98146A1 (sh)
TW (1) TW538043B (sh)
UY (1) UY25113A1 (sh)
WO (1) WO1999006430A1 (sh)
YU (1) YU2500A (sh)
ZA (1) ZA986874B (sh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20010635A1 (es) * 1999-10-08 2001-08-15 Smithkline Beecham Corp Inhibidores de fab i utiles para el tratamiento de infecciones bacterianas
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
DK1560584T3 (da) 2001-04-06 2009-05-18 Affinium Pharm Inc Fab I inhibitorer
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
KR101299399B1 (ko) 2004-06-04 2013-08-22 아피늄 파마슈티컬스, 인크. 치료제, 및 그의 제조 및 사용 방법
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
EP2125802A4 (en) * 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
BR122021020778B1 (pt) 2012-06-19 2022-07-12 Debiopharm International Sa Derivados de pró-fármaco de (e)-n-metil-n-((3-metilbenzofuran-2-il) metil)-3-(7-oxo-5,6,7,8-tetraidro- 1, 8- naftirindin-3-il) acrilamida
RU2716164C2 (ru) * 2014-04-25 2020-03-06 Наурекс, Инк. Стабильные композиции нейроактивных пептидов
SI3419628T1 (sl) 2016-02-26 2021-03-31 Debiopharm International Sa Zdravilo za zdravljenje infekcij diabetičnega stopala
WO2019148294A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Dimeric dexamethasone prodrug compositions and uses thereof
CN113661170B (zh) 2019-02-01 2025-04-15 波纹疗法公司 地塞米松二聚体的结晶形式及其用途
PH12021551922A1 (en) 2019-02-14 2022-05-23 Debiopharm Int Sa Afabicin formulation, method for making the same
UA129222C2 (uk) 2019-06-14 2025-02-12 Дебіофарм Інтернешнл С.А. Лікарський засіб і його застосування для лікування бактеріальних інфекцій, пов'язаних з біоплівкою
WO2021024039A1 (en) 2019-08-07 2021-02-11 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependance disorders
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
CZ286896B6 (en) 1994-01-18 2000-07-12 Pfizer Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
JP3145715B2 (ja) 1995-06-06 2001-03-12 ファイザー・インコーポレーテッド 無水7−([1α,5α,6α]−6−アミノ−3−アザビシクロ[3.1.0]ヘキサ−3−イル)−6−フルオロ−1−(2,4−ジフルオロフェニル)−1,4−ジヒドロ−4−オキソ−1,8−ナフチリディン−3−カルボン酸メタンスルホン酸塩の新規な結晶形態
DK0833837T3 (da) * 1995-06-15 2002-09-02 Pfizer Fremgangsmåde til fremstilling af derivater af azabicyclonaphthydridincarboxylsyre omfattende et dipeptid
CA2230303C (en) * 1995-08-29 2001-07-24 Douglas J. M. Allen Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
CA2229786C (en) 1995-08-29 2002-02-19 David Bruning Joseph Zwitterionic forms of trovafloxacin
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
SK1012000A3 (en) 2000-09-12
CA2296466A1 (en) 1999-02-11
DZ2576A1 (fr) 2003-02-22
CN1265671A (zh) 2000-09-06
EA200000086A1 (ru) 2000-08-28
ID24374A (id) 2000-07-13
AU734863B2 (en) 2001-06-21
NO20000485L (no) 2000-03-27
YU2500A (sh) 2002-09-19
PA8456701A1 (es) 2000-05-24
PE103799A1 (es) 1999-10-25
PL338477A1 (en) 2000-11-06
AP1031A (en) 2001-12-21
BR9811580A (pt) 2000-08-22
AU8236898A (en) 1999-02-22
IL134156A0 (en) 2001-04-30
JP2001512133A (ja) 2001-08-21
JP3463928B2 (ja) 2003-11-05
DK1000086T3 (da) 2004-05-17
US6194429B1 (en) 2001-02-27
PT1000086E (pt) 2004-05-31
ES2214716T3 (es) 2004-09-16
OA11281A (en) 2002-11-19
NZ502249A (en) 2001-11-30
MA24626A1 (fr) 1999-04-01
ATE259827T1 (de) 2004-03-15
TNSN98146A1 (fr) 2005-03-15
BG104105A (bg) 2000-08-31
CA2296466C (en) 2003-04-15
EP1000086A1 (en) 2000-05-17
IS5339A (is) 2000-01-14
TW538043B (en) 2003-06-21
HUP0004793A3 (en) 2001-10-29
AP9801310A0 (en) 1998-09-30
KR20010022495A (ko) 2001-03-15
DE69821767D1 (de) 2004-03-25
GT199800112A (es) 2000-01-15
CO4970688A1 (es) 2000-11-07
HUP0004793A2 (hu) 2001-04-28
AR015417A1 (es) 2001-05-02
ZA986874B (en) 2000-01-31
NO20000485D0 (no) 2000-01-31
EP1000086B1 (en) 2004-02-18
HRP980417B1 (en) 2002-10-31
WO1999006430A1 (en) 1999-02-11
HN1998000106A (es) 1999-01-08
DE69821767T2 (de) 2005-01-13
HRP980417A2 (en) 1999-08-31
EA002120B1 (ru) 2001-12-24

Similar Documents

Publication Publication Date Title
UY25113A1 (es) Composiciones parenterales de alatrofloxacino
BR0012243A (pt) Triflúor butenos nematocidas
BR0215405A (pt) Composições e processos de uso de collajolie
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
GB0011203D0 (en) Chemical compounds
MXPA04004939A (es) 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion.
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
KR960702830A (ko) 방사선 보호제로서의 N-알킬티오 폴리아민 유도체(N-Alkylthio polyaine derivatives as radioprotective agents)
ATE288900T1 (de) Substituierte benzoylcyclohexandione
ATE297903T1 (de) Substituierte phenyluracile
MY118131A (en) Dihydropyrones with improved antiviral activity
TR200002019T2 (tr) 1,3,4-Okzadiazolon türevleri.
BR9902084A (pt) Heterociclos.
DK1056754T3 (da) Phosphatderivater af diaryl-1,3,4-oxadiazolon
BR0012751A (pt) Benzofuranos serotonérgicos
NO20002191L (no) Dofetilid polymorfer
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
GB9806409D0 (en) Processes for preparing intermediates
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
DK1051404T3 (da) Substituerede phenyluraciler med herbicid virkning
AR020785A1 (es) Nuevos procedimientos quimicos
ES2085023T3 (es) Procedimientos para la produccion de zidovudina.
DK1194158T3 (da) Anvendelse af UK 114-proteiner til hæmning af organtransplantatafstödning
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
DK1157140T3 (da) Anvendelse af zinklegeringer

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20071105